PEPIN RONALD bought CLDX
December 15, 2025 · Form 4 insider transaction
PEPIN RONALD bought 8,333 shares of Celldex Therapeutics, Inc. at $9.02 per share, a transaction worth $75.1K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
8,333
Price
$9.02
Total value
$75.1K
InsiderPEPIN RONALD
RoleOfficer
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateDecember 15, 2025
Filing dateDecember 17, 2025
Shares owned after9,097
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
On February 8, 2019, Celldex Therapeutics, Inc. effected a 1-for-15 reverse stock split of its common stock (the "Reverse Stock Split"). This option was previously reported as covering 200,000 shares at an exercise price of $0.6011 per share, but has been adjusted to reflect the Reverse Stock Split.; Includes 764 shares of common stock acquired under the Celldex Therapeutics, Inc. 2004 Employee Stock Purchase Plan.